Filing Details

Accession Number:
0001235802-23-000071
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-26 16:26:41
Reporting Period:
2023-06-23
Accepted Time:
2023-06-26 16:26:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401040 Diamedica Therapeutics Inc. DMAC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1872863 Pauling Charles Semba 301 Carlson Parkway, Suite 210
Minneapolis MN 55305
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Shares, No Par Value Per Share Acquisiton 2023-06-23 12,787 $3.91 29,943 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 12,867 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.